Workshop on the development of antimicrobial medicinal products for paediatric patients

EventCorporate

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

Date: czwartek, 21 Czerwiec 2018, Cały dzień
Miejsce: European Medicines Agency, Amsterdam, the Netherlands

The European Medicines Agency, the Japanese Pharmaceuticals and Medical Devices Agency and the United States' Food and Drug Administration co-organised this workshop to discuss the development of antibiotics for children. This provides an opportunity for international regulators to explore with medicine developers, clinicians and clinical trial investigators, clinical development plans that would allow for the timely development of antibiotics for children and discuss a regulatory pathway for their approval.

Documents

Agenda - Workshop on development of antibacterial medicinal products for paediatric patients

English (EN) (488.47 KB - PDF)

Opublikowane po raz pierwszy: 24/05/2018 Ostatnia aktualizacja: 29/10/2018

Presentation - Anti-infective drug development in neonates (S.Nambiar, FDA)

English (EN) (385.36 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Studying neonates: A not-for-profit developers perspective (M.Balasegaram, GARDP)

English (EN) (1.22 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Anti-Infectives and Neonates (D.Benjamin, Duke University)

English (EN) (558.71 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Challenges in conducting trials involving children: Sponsor’s view (G. Noel; S.Cammarata)

English (EN) (662.45 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - General considerations for the development of antibacterial drugs for children - U.S. FDA perspective (J.Farley, FDA)

English (EN) (386.68 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Issues in conducting clinical trials in children and neonates: site PI perspective (T.Metsvaht, University of Tartu)

English (EN) (4.14 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Neonates need more finesse in dosing of antibiotics (K.Allegaert, KU Leuven)

English (EN) (2.87 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Overview of neonatal studies in paediatric investigational plans (M.Cortizo, IDWP/PDCO)

English (EN) (169.54 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Pharmacokinetic-Pharmacodynamic (PKPD) modelling to inform efficacyin paediatric antimicrobial trials (J.Standing, UCL)

English (EN) (1.65 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - PMDA perspective: Ongoing activities and requirements for developing antibacterial agents for children (J.Sato, PMDA)

English (EN) (2.76 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Safety assessment in paediatric antibiotics clinical trials (M.Sharland, St.George's University of London)

English (EN) (1.7 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - Studying neonates: Workshop on development of antibacterial products for paediatric patients (M.Johnson)

English (EN) (262.61 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - The paediatrica ddendum to the antibacterial agents guideline (M.Fernandez Cortizo, IDWP/PDCO)

English (EN) (277.74 KB - PDF)

Opublikowane po raz pierwszy: 29/10/2018

Presentation - The right dose - Application of PK/PD modeling in pediatric antibiotic development (M.Cohen-Wolkowiez, Duke University)

English (EN) (1.86 MB - PDF)

Opublikowane po raz pierwszy: 29/10/2018